Clinical trial registry record

Metformin and Longevity Genes in Prediabetes

A registered PHASE4 study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.

Plain-language guide

Five questions to ask about this record

What this is
A clinical study registration, not a result or recommendation.
Why it may matter
The registry currently reports Completed.
Evidence
Registered phase 4 study.
Main limitation
Registration does not prove that the intervention works, is safe, or is available to you.
What changed
Registry metadata was last updated March 13, 2013.
Where to verify
Open the primary registry below for eligibility, locations, contacts, and current status.
Registry ID
NCT01765946
Last registry update
March 13, 2013
Status
Completed
Phase
Phase 4
Sponsor
University of Padova
Enrollment
38
Countries
Italy
Match confidence
100%
Source feed
ClinicalTrials.gov
Automated source synopsis

A registered PHASE4 study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.

Evidence snapshot

What the source actually supports

Evidence stage
Phase 4
Study design
RANDOMIZED · PARALLEL · TREATMENT · SINGLE
Evidence population
Human clinical study registration
Participants
38
Population
ALL · 40 Years to 75 Years
Duration
2010-06-01 to 2013-03-01
Intervention
Metformin; placebo
Comparator
Placebo
Outcomes measured
Longevity gene expression — 2 month after treatment; Insulin sensitivity — 2 months after treatment; Monocyte polarization status — 2 months after treatment
Reported result
No reusable finding-level result is available in this record.

Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.

Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.

Source supportStructured registry protocol metadata; no finding-level conclusion is generated.

Trial stage · Phase 4A trial phase describes development stage; it does not establish a positive result.
Phase 1Phase 2Phase 3Phase 4

Registration and recruitment status do not establish safety, efficacy, or regulatory approval.

Why this record appears here · 100% topic match

The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.

  • Longevity genetics · 100%Title contains controlled term: longevity gene. Abstract contains controlled term: longevity gene. Title supplies longevity context: longevity. Study type is explicitly identified as INTERVENTIONAL.
  • Metformin · 100%Title contains controlled term: metformin. Abstract contains controlled term: metformin. Source terminology contains: metformin. Title supplies longevity context: longevity. Study type is explicitly identified as INTERVENTIONAL.

Automated source check 100% · update recency 35%. These figures help sort records; they are not medical ratings.

longevity geneticsmetformin
Open primary sourceExport JSON